Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach

M Aliyu, FT Zohora, AU Anka, K Ali, S Maleknia… - International …, 2022 - Elsevier
Several studies have shown that interleukin 6 (IL-6) is a multifunctional cytokine with both
pro-inflammatory and anti-inflammatory activity, depending on the immune response …

[HTML][HTML] Hyperinflammatory response in COVID-19: a systematic review

MJA Silva, LR Ribeiro, MIM Gouveia, BR Marcelino… - Viruses, 2023 - mdpi.com
COVID-19 is a multisystemic disease caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). The immunopathogenic conditions of the hyperinflammatory …

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper

T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022 - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …

[HTML][HTML] Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State

A Libra, N Ciancio, G Sambataro, E Sciacca… - Viruses, 2023 - mdpi.com
Remdesivir is one of the most attractive options for patients with hypoxemic respiratory
failure due to coronavirus disease 2019 (COVID-19). The aim of our study was to evaluate …

[HTML][HTML] Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19

S Chen, C Zhang, D Chen, L Dong, T Chang… - Frontiers in …, 2023 - frontiersin.org
Nowadays, people have relaxed their vigilance against COVID-19 due to its declining
infection numbers and attenuated virulence. However, COVID-19 still needs to be concern …

[HTML][HTML] Comparison of physical and biochemical characterizations of sars-cov-2 inactivated by different treatments

S Yu, Y Wei, H Liang, W Ji, Z Chang, S Xie, Y Wang… - Viruses, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused huge social
and economic distress. Given its rapid spread and the lack of specific treatment options …

[HTML][HTML] A clinical update on SARS-CoV-2: Pathology and development of potential inhibitors

DD Singh, I Han, EH Choi, DK Yadav - Current Issues in Molecular …, 2023 - mdpi.com
SARS-CoV-2 (severe acute respiratory syndrome) is highly infectious and causes severe
acute respiratory distress syndrome (SARD), immune suppression, and multi-organ failure …

[HTML][HTML] A review of potential therapeutic strategies for COVID-19

J Meng, R Li, Z Zhang, J Wang, Q Huang, D Nie, K Fan… - Viruses, 2022 - mdpi.com
Coronavirus disease 2019 is a rather heterogeneous disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The ongoing pandemic is a global threat …

[HTML][HTML] Legionella pneumophila pneumonia: A 5‑year retrospective clinical evaluation and commentary

A Marino, S Stracquadanio… - World …, 2023 - … .spandidos-publications.com
Although legionellosis represents a widely underestimated disease for various reasons, the
rate of Legionella pneumophila infections has increased steadily over the past 30 years. The …

COVID‑19 infection and severe autoimmune haemolytic anaemia: A case report and review of the literature

Y Russotto, C Micali, A Marino… - World Academy of …, 2023 - spandidos-publications.com
During the ongoing coronavirus disease 2019 (COVID‑19) pandemic, a number of
autoimmune diseases have been found to be associated with severe acute respiratory …